Heparin disaccharide II-H sodium, with the CAS number 136098-02-7, is a chemically modified form of heparin, a naturally occurring anticoagulant. This substance is characterized by its structure, which consists of repeating disaccharide units that include glucuronic acid and N-acetylglucosamine. The sodium salt form enhances its solubility in aqueous solutions, making it suitable for various pharmaceutical applications. Heparin disaccharide II-H sodium exhibits anticoagulant properties by inhibiting thrombin and factor Xa, thereby playing a crucial role in preventing blood clot formation. Its use is particularly significant in clinical settings for the treatment and prevention of thromboembolic disorders. Additionally, this compound may have implications in research related to cell signaling, inflammation, and tissue repair due to its interactions with various proteins and growth factors. Overall, heparin disaccharide II-H sodium is an important compound in both therapeutic and research contexts, reflecting the diverse roles of glycosaminoglycans in biological systems.

heparin disaccharide ii-H sodium

136098-02-7: hexose, 2-amino-2-deoxy-4-O-(4-deoxyhex-4-enopyranuronosyl)-, 6-(hydrogen sulfate), monosodium salt

Heparin disaccharide II-H sodium salt

Heparin disaccharide II-H disodium salt is a complex carbohydrate with the chemical formula C3H6Na2O14. It has a molecular weight of 617.8 and a melting point of 204.5°C. The compound has been modified by methylation, glycosylation, fluorination, and click modification. It is a synthetic oligosaccharide with high purity and custom synthesis.

CAS 136098-02-7: heparin disaccharide ii-H sodium

Heparin disaccharide II-H sodium salt

Ref: 7W-GC7839

Heparin disaccharide II-H disodium salt

Ref: 3D-OH28915